A Single Arm, Observational Clinical Trial to Evaluate the Efficacy and Safety of Combination Treatment With PD-1 Monoclonal Antibody Plus Apatinib and SBRT in HCC With PVTT
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Rivoceranib (Primary) ; Toripalimab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 19 Nov 2019 New trial record